Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study

Takafumi Ueda, Norifumi Naka, Nobuhito Araki, Takeshi Ishii, Hiroyuki Tsuchiya, Hideki Yoshikawa, Kazuo Mochizuki, Tadao Tsuboyama, Junya Toguchida, Toshifumi Ozaki, Hiroaki Murata, Ikuo Kudawara, Kazuhiro Tanaka, Yukihide Iwamoto, Yasuo Yazawa, Kazuyoshi Kushida, Takanobu Otsuka, Keiji Sato

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background. The radiographic evaluation of the response to preoperative chemotherapy for bone and soft tissue sarcomas is based mostly on the change in primary tumor size before and after chemotherapy, as is done for many solid cancers. Its prognostic correlation, however, has hardly been validated. Methods. We conducted a retrospective validation study of the Japanese Orthopaedic Association (JOA) radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas as a JOA Committee on Musculoskeletal Tumors cooperative study. A total of 125 consecutive patients with high-grade bone (n = 77) and soft tissue (n = 48) sarcomas treated with neoadjuvant chemotherapy and definitive surgery in 25 tertiary referral hospitals were selected for the study. We investigated the correlation between the tumor size-based radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas provided by the JOA Committee on Musculoskeletal Tumors (hereafter called the JOA criteria) and the patients' overall survival using the Kaplan-Meier method and the log-rank test. Results. The JOA criteria correlated relatively well with survival for malignant bone tumors (mostly comprising osteosarcoma and Ewing's sarcoma) but not for soft tissue sarcomas, suggesting that the tumor size-based radiographic evaluation criteria for the response to preoperative chemotherapy in patients with soft tissue sarcomas is invalid. Conclusions. The JOA criteria, based on the change in primary tumor size, is valid for malignant bone tumors but invalid for soft tissue sarcomas. Other new evaluation modalities of the response to preoperative chemotherapy using innovative functional imaging techniques are needed for soft tissue sarcomas.

Original languageEnglish
Pages (from-to)304-312
Number of pages9
JournalJournal of Orthopaedic Science
Volume13
Issue number4
DOIs
Publication statusPublished - Jul 2008

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study'. Together they form a unique fingerprint.

  • Cite this

    Ueda, T., Naka, N., Araki, N., Ishii, T., Tsuchiya, H., Yoshikawa, H., Mochizuki, K., Tsuboyama, T., Toguchida, J., Ozaki, T., Murata, H., Kudawara, I., Tanaka, K., Iwamoto, Y., Yazawa, Y., Kushida, K., Otsuka, T., & Sato, K. (2008). Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study. Journal of Orthopaedic Science, 13(4), 304-312. https://doi.org/10.1007/s00776-008-1235-5